Theranos founder Elizabeth Holmes is expected to leave her Texas federal prison in August 2027, years before completing her original 11-year sentence for defrauding investors, after a judge cut her prison term and federal credits accelerated her release timeline.
Holmes, 42, has been approved for transfer to the Austin Transitional Center, a halfway house in Del Valle, Texas, on August 23, 2027. The move will allow her to leave the prison facility while continuing to serve her sentence in federal custody. Her projected release date is February 22, 2030, when she is expected to begin three years of supervised release.
U.S. District Judge Edward J. Davila in California reduced her prison term from 135 months to 123 months on March 26, 2026, after rejecting prosecutors' argument that the massive losses caused by the Theranos fraud should disqualify her from a sentencing adjustment.
Davila found insufficient evidence that individual investors suffered the specific financial hardship required to exclude Holmes from the reduction, despite the hundreds of millions of dollars lost in the scheme.
Holmes was convicted in January 2022 on three counts of wire fraud and one count of conspiracy to commit wire fraud after misleading investors about Theranos' blood-testing technology. The company, once valued at $9 billion, claimed it could perform numerous medical tests using just a few drops of blood. She began serving her sentence at Federal Prison Camp Bryan in Texas on May 30, 2023.
Her convictions, original sentence, and restitution order were upheld by the Ninth U.S. Circuit Court of Appeals in February 2025. Holmes later sought a reduction under Amendment 821 to the U.S. Sentencing Guidelines, which allows certain defendants with no criminal-history points to receive a lower sentencing range if they meet additional requirements.
The dispute centered on whether Holmes had personally caused "substantial financial hardship" to her victims. Under the guidelines, courts consider whether a crime forced victims into bankruptcy, depleted significant savings, or required major changes to their employment, housing, or financial arrangements.
Holmes' lawyers pointed to investment agreements in which Theranos investors acknowledged they could withstand the complete loss of their investments without damaging their financial condition. Prosecutors cited the enormous losses, but the court found that the record did not establish qualifying hardship to any individual victim.
Davila granted the reduction while emphasizing the seriousness of the fraud. Holmes and former Theranos president Ramesh "Sunny" Balwani remain jointly responsible for $452,047,268 in restitution to 12 investor victims, including Walgreens and Safeway.
Her approved transfer became public in September 2026 through the Department of Justice's Victim Notification System. At the halfway house, Holmes would be allowed to work outside the facility while remaining subject to federal custody requirements.
The case has drawn renewed attention following the October 16 release of You Can See Everything, a documentary directed by Nathan Fielder and Lance Oppenheim. The film follows the former Silicon Valley executive during her final weeks before entering prison and revisits the scandal that brought down Theranos.
Beyond the one-year sentence reduction, Holmes has benefited from federal prison credits under the First Step Act, which have further advanced her release timeline and transition to community-based custody.